Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Accumulated Depreciation: 2020-2022

Historic Accumulated Depreciation for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $1.1 million.

  • Candel Therapeutics' Accumulated Depreciation rose 102.42% to $1.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.8 million, marking a year-over-year increase of 102.42%. This contributed to the annual value of $1.1 million for FY2022, which is 220.74% up from last year.
  • According to the latest figures from FY2022, Candel Therapeutics' Accumulated Depreciation is $1.1 million, which was up 220.74% from $352,000 recorded in FY2021.
  • In the past 5 years, Candel Therapeutics' Accumulated Depreciation ranged from a high of $1.1 million in FY2022 and a low of $134,000 during FY2020.
  • In the last 3 years, Candel Therapeutics' Accumulated Depreciation had a median value of $352,000 in 2021 and averaged $538,333.
  • Data for Candel Therapeutics' Accumulated Depreciation shows a peak YoY surged of 220.74% (in 2022) over the last 5 years.
  • Candel Therapeutics' Accumulated Depreciation (Yearly) stood at $134,000 in 2020, then surged by 162.69% to $352,000 in 2021, then surged by 220.74% to $1.1 million in 2022.